Analysed STOKE THERAPEUTICS INC (STOK:NASDAQ) News Sources
Stoke Therapeutics shares rise as JPMorgan starts coverage with Overweight rating
21-08-2026
advfn.com
What Is Stoke Therapeutics (STOK) Signaling With A 2 Million Share Shelf Filing?
07-08-2026
yahoo.com
Stoke Therapeutics’ Dravet Trial Tops Enrollment Target With Zero Dropouts
18-08-2026
marketbeat.com
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
03-09-2026
yahoo.com
Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting
06-10-2026
yahoo.com
FDA Alignment on Zorevunersen Endpoints Could Be A Game Changer For Stoke Therapeutics (STOK)
09-10-2026
yahoo.com
Stoke Therapeutics Presents Data Supporting the Disease-Modifying Potential of STK-002 in Autosomal Dominant Optic Atrophy (ADOA) at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting
12-10-2026
yahoo.com
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
16-10-2026
yahoo.com
What is the current price of STOKE THERAPEUTICS INC (STOK:NASDAQ)?
The current price of STOKE THERAPEUTICS INC (STOK:NASDAQ) is $26.13.
STOKE THERAPEUTICS INC (STOK:NASDAQ) absolute price change since previous trading day?
The absolute price change of STOKE THERAPEUTICS INC (STOK:NASDAQ) since the previous trading day is $0.67.
STOKE THERAPEUTICS INC (STOK:NASDAQ) percentage price change since previous trading day?
The percentage price change of STOKE THERAPEUTICS INC (STOK:NASDAQ) since the previous trading day is 2.6316%.
What is the most recent average sentiment score for STOKE THERAPEUTICS INC (STOK:NASDAQ)?
The most recent average sentiment score for STOKE THERAPEUTICS INC (STOK:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for STOKE THERAPEUTICS INC (STOK:NASDAQ)?
The most recent sentiment for STOKE THERAPEUTICS INC (STOK:NASDAQ) is .
SEC-8K** Filing Available For STOKE THERAPEUTICS INC (STOK:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.